Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Creutzig

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1987
Comparison of Laser-Doppler-Flux and tcPO2 in healthy probands and patients with arterial ischemiaL Caspary, A Creutzig, K Alexander
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1990
[Duplex ultrasound measurement of morphologic parameters before and following repeated puncture of the femoral artery for intermittent infusion therapy]C Ranke, A Creutzig, K Alexander
European Journal of Clinical Investigation|December 1, 1986
Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive diseaseA Creutzig, H Creutzig, K Alexander
VASA. Zeitschrift Fur Gefasskrankheiten|March 25, 2000
[Therapy of venous thromboembolism with low-molecular-weight heparins]S Haas, P Haas, A Creutzig
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1993
Variability of TcPO2-measurements at 37 degrees C and 44 degrees C in patients with claudication in consideration of provocation testsL Caspary, A Creutzig, K Alexander
VASA. Zeitschrift Fur Gefasskrankheiten|August 1, 1997
Changes of dermal haemoglobin oxygenation and concentration in healthy subjects and in patients with peripheral arterial occlusive disease during and after acute ischemiaJ Thum, L Caspary, A Creutzig
Annals of Internal Medicine|September 1, 1996
The Raynaud phenomenon and interferon therapyA Creutzig, L Caspary, M Freund
VASA. Supplementum|January 1, 1992
[Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease]A Creutzig, L Caspary, K Alexander
Medizinische Klinik (Munich, Germany : 1983)|April 15, 1995
[Traumatically-induced ischemia of the hands]M Schneider, A Creutzig, K Alexander
European Journal of Clinical Pharmacology|January 1, 1991
Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculationL Caspary, A Creutzig, K Alexander
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Advances in Experimental Medicine and Biology|January 1, 1987
Comparison of Laser-Doppler-Flux and tcPO2 in healthy probands and patients with arterial ischemiaL Caspary, A Creutzig, K Alexander
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1990
[Duplex ultrasound measurement of morphologic parameters before and following repeated puncture of the femoral artery for intermittent infusion therapy]C Ranke, A Creutzig, K Alexander
European Journal of Clinical Investigation|December 1, 1986
Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive diseaseA Creutzig, H Creutzig, K Alexander
VASA. Zeitschrift Fur Gefasskrankheiten|March 25, 2000
[Therapy of venous thromboembolism with low-molecular-weight heparins]S Haas, P Haas, A Creutzig
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1993
Variability of TcPO2-measurements at 37 degrees C and 44 degrees C in patients with claudication in consideration of provocation testsL Caspary, A Creutzig, K Alexander
VASA. Zeitschrift Fur Gefasskrankheiten|August 1, 1997
Changes of dermal haemoglobin oxygenation and concentration in healthy subjects and in patients with peripheral arterial occlusive disease during and after acute ischemiaJ Thum, L Caspary, A Creutzig
Annals of Internal Medicine|September 1, 1996
The Raynaud phenomenon and interferon therapyA Creutzig, L Caspary, M Freund
VASA. Supplementum|January 1, 1992
[Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease]A Creutzig, L Caspary, K Alexander
Medizinische Klinik (Munich, Germany : 1983)|April 15, 1995
[Traumatically-induced ischemia of the hands]M Schneider, A Creutzig, K Alexander
European Journal of Clinical Pharmacology|January 1, 1991
Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculationL Caspary, A Creutzig, K Alexander
Pageof 15